PubRank

Erik Jakobsen

Author PubWeight™ 16.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer. Ann Thorac Surg 2013 2.26
2 Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax 2013 2.19
3 Phase III trial comparing three doses of docetaxel for second-line treatment of advanced breast cancer. J Clin Oncol 2006 1.60
4 High procedure volume is strongly associated with improved survival after lung cancer surgery. J Clin Oncol 2013 1.31
5 The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. Eur J Cancer 2012 1.01
6 The effect of different comorbidities on survival of non-small cells lung cancer patients. Lung 2014 0.95
7 The direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival, staging and resection models with missing measurements in covariates. BMJ Open 2014 0.92
8 Post-mastectomy radiotherapy in Denmark: from 2D to 3D treatment planning guidelines of The Danish Breast Cancer Cooperative Group. Acta Oncol 2008 0.92
9 Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009. Thorax 2013 0.90
10 Socioeconomic position and surgery for early-stage non-small-cell lung cancer: A population-based study in Denmark. Lung Cancer 2012 0.85
11 The European initiative for quality management in lung cancer care. Eur Respir J 2014 0.83
12 Socioeconomic position and survival after lung cancer: Influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010. Acta Oncol 2015 0.81
13 Role of comorbidity on survival after radiotherapy and chemotherapy for nonsurgically treated lung cancer. J Thorac Oncol 2015 0.79
14 Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1. Acta Oncol 2011 0.79
15 Feasibility of a psychosocial rehabilitation intervention to enhance the involvement of relatives in cancer rehabilitation: pilot study for a randomized controlled trial. Patient 2013 0.78
16 Uncertain added value of Global Trigger Tool for monitoring of patient safety in cancer care. Dan Med Bull 2011 0.77
17 [Quality assurance and clinical databases]. Ugeskr Laeger 2002 0.75
18 DBCG trial 89B comparing adjuvant CMF and ovarian ablation: similar outcome for eligible but non-enrolled and randomized breast cancer patients. Acta Oncol 2008 0.75